TAZICEF

Product NDC: 0409-5092
11-digit product format: 004095092
Labeler code: 0409
Product ID: 0409-5092_3f749ee0-db14-4ed0-9056-d545a38bbe3b
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: CEFTAZIDIME
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Labeler: Hospira, Inc.
Application: ANDA064032
Marketing category: ANDA
Marketing start: 2006-05-08
Substance: CEFTAZIDIME
Active strength: 1 g/1
Pharmacologic classes: Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	0409-5092		D	Discontinued by firm		2026-08-03
excluded package	package	0409-5092	0409-5092-16	D	Discontinued by firm		2026-08-03

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A064032-001	TAZICEF	CEFTAZIDIME	1GM/VIAL	INJECTABLE / INJECTION	AP		1993-10-31
A064032-002	TAZICEF	CEFTAZIDIME	2GM/VIAL	INJECTABLE / INJECTION	AP		1993-10-31

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A064032-001	AP
A064032-002	AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A064032-001	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A064032-002	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1993-10-31	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A064032-001	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A064032-002	AP	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A064032-001	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A064032-002	AP	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A064032-001	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A064032-002	AP	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A064032-001	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A064032-002	AP	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A064032-001	AP	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A064032-002	AP	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A064032-001	AP	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A064032-002	AP	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A064032-001	AP	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A064032-002	AP	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A064032-001	AP	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A064032-002	AP	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A064032-001	AP	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A064032-002	AP	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A064032-001	AP	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A064032-002	AP	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A064032-001	AP	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A064032-002	AP	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A064032-001	AP	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A064032-002	AP	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A064032-001	AP	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A064032-002	AP	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A064032-001	AP	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A064032-002	AP	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A064032-001	AP	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A064032-002	AP	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A064032-001	AP	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A064032-002	AP	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A064032-001	AP	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A064032-002	AP	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A064032-001	AP	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A064032-002	AP	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A064032-001	AP	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A064032-002	AP	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A064032-001	AP	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A064032-002	AP	1	`782e0a99824c…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
fb7d24f2-fcd1-4dc6-b9d0-b1f65bfffab5	Product name	1	20150409

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0409-5092-11	TAZICEF	1 in 1 VIAL, PATENT DELIVERY SYSTEM	INJECTION, POWDER, FOR SOLUTION	1		29
0409-5092-16	TAZICEF	25 in 1 TRAY	INJECTION, POWDER, FOR SOLUTION	25		29

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0409-5092-11	EA - Each	0409-5092	31a8b96a-ce51-4979-91cd-37556810afa6	1	2019-08-06
0409-5092-16	EA - Each	0409-5092	3fa85688-74be-4814-9abe-b8a105760bc3	1	2012-07-24
0409-5092-52	EA - Each	0409-5092	0b0a3b10-f7ab-4f39-b690-32033459d70c	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CEFTAZIDIME	ACTIVE INGREDIENT	9M416Z9QNR	TAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.]	14
CEFTAZIDIME ANHYDROUS	ACTIVE MOIETY	DZR1ENT301	TAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.]	14
SODIUM CARBONATE	INACTIVE INGREDIENT	45P3261C7T	TAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.]	14

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0409-5092	TAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.]	29	Current NDC, Legacy NDC, 2 package rows	20211103_9b73979c-c95a-4433-0a9d-f9cea3cb557f.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
TAZICEF	CEFTAZIDIME	Hospira, Inc.	9b73979c-c95a-4433-0a9d-f9cea3cb557f	2026-06-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 064032 application number: ANDA064032 ndc (product): 0409-5092

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
9M416Z9QNR	CEFTAZIDIME	78439-06-2	CEFTAZIDIME

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1659283	cefTAZidime 1 GM Injection	PSN	9b73979c-c95a-4433-0a9d-f9cea3cb557f	29
1659287	cefTAZidime 2 GM Injection	PSN	9b73979c-c95a-4433-0a9d-f9cea3cb557f	29
1659292	Tazicef 1 GM Injection	PSN	9b73979c-c95a-4433-0a9d-f9cea3cb557f	29
1659294	Tazicef 2 GM Injection	PSN	9b73979c-c95a-4433-0a9d-f9cea3cb557f	29
1659292	ceftazidime 1000 MG Injection [Tazicef]	SBD	9b73979c-c95a-4433-0a9d-f9cea3cb557f	29
1659294	ceftazidime 2000 MG Injection [Tazicef]	SBD	9b73979c-c95a-4433-0a9d-f9cea3cb557f	29
1659283	ceftazidime 1000 MG Injection	SCD	9b73979c-c95a-4433-0a9d-f9cea3cb557f	29
1659287	ceftazidime 2000 MG Injection	SCD	9b73979c-c95a-4433-0a9d-f9cea3cb557f	29
1659283	ceftazidime (as ceftazidime pentahydrate) 1000 MG Injection	SY	9b73979c-c95a-4433-0a9d-f9cea3cb557f	29
1659287	ceftazidime (as ceftazidime pentahydrate) 2000 MG Injection	SY	9b73979c-c95a-4433-0a9d-f9cea3cb557f	29
1659283	ceftazidime 1 GM Injection	SY	9b73979c-c95a-4433-0a9d-f9cea3cb557f	29
1659287	ceftazidime 2 GM Injection	SY	9b73979c-c95a-4433-0a9d-f9cea3cb557f	29
1659292	Tazicef 1000 MG Injection	SY	9b73979c-c95a-4433-0a9d-f9cea3cb557f	29
1659294	Tazicef 2000 MG Injection	SY	9b73979c-c95a-4433-0a9d-f9cea3cb557f	29

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
0409-5092-11	00409509211	1 in 1 VIAL, PATENT DELIVERY SYSTEM					Historical
0409-5092-16	00409509216	25 VIAL, PATENT DELIVERY SYSTEM in 1 TRAY (0409-5092-16) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, PATENT DELIVERY SYSTEM (0409-5092-11)	2006-05-08	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
TAZICEF ® brand of ceftazidime for injection, USP	Hospira, Inc. \| Sandoz GmbH	2026-06-04	HUMAN PRESCRIPTION DRUG LABEL	30